Medtech accelerator and nonprofit global competition group Medtech Innovator said today that Baxter (NYSE:BAX) has joined on as a partner to the program.
Baxter will join Becton Dickinson & Co. (NYSE:BDX), Johnson & Johnson (NYSE:JNJ), AdvaMed, RCT Ventures, Wilson Sonsini Goodrich & Rosati and Innovation in Medtech in its partnership with the group, which will award more than $500,000 in cash prizes, scholarships and services in its 2017 competition.
“For more than 85 years, Baxter has been a pioneer of healthcare. We are advancing the frontiers of care with innovative new therapies and technologies focused on improving outcomes, safety and value while broadening access to patients. We are proud to partner with MedTech Innovator to identify and assist emerging companies around the world and to collaborate with our peers to transform healthcare,” Baxter Ventures head Anne Sissel said in a prepared release.
The group said that applications for its 2017 contest are now open, with a deadline of Feb. 28.
“MedTech Innovator is the industry’s platform to find the best new medical technologies and digital health products, and we rely on the leading players to provide guidance, feedback, and evaluation to these transformative startups. We are pleased to welcome Baxter as our newest partner to help achieve this goal and further our mission,” MedTech Innovator CEO Paul Grand said in a press release.
